In the Media
InMed Biosynthesis Platform – Potential to Produce High Quality Pharmaceutical-Grade Cannabinoids Efficiently
InMed is a biopharmaceutical company that specializes in the discovery and development of novel, cannabinoid-based therapeutics for the treatment of diseases with high unmet medical...
Eric A. Adams talks with BTV about InMed’s biosynthesis of cannabinoids
In this video, InMed CEO Eric A. Adams speaks with BTV about InMed's focus on cannabinoid-based pharmaceutical products. Mr. Adams talks about the company's proprietary...
Cannabinoid Based Pharmaceutical Product May Help Rare Skin Disease
InMed is a bio-pharmaceutical company that specializes in the research development and commercialization of cannabinoid based pharmaceutical products. We take this class of compounds known...
UBC’s Dr. Yadav Talks about the How Biosynthesis May Efficiently Produce Cannabinoids
InMed and the laboratory of Dr. Vikramaditya Yadav at the University of British Columbia collaborate on a proprietary biosynthesis technology to produce bioidentical, high purity,...
UBC’s Dr. Yadav Talks about Producing Bio-identical Cannabinoids in the Lab using Biosynthesis
In this video, Dr. Vikramaditya Yadav of the University of British Columbia talks about using a unique biosynthesis platform to productively produce bioidentical, high purity,...
Video: InMed CEO Eric A. Adams – how InMed is different from competitors
In this video, InMed CEO Eric A. Adams talks about how InMed is differentiated from competitors. InMed does not grow cannabis. We biosynthesize the compounds...